Aminoglycoside-associated acute kidney injury in elderly patients with and without shock

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 11, 2016, Pages 3250-3257

  Ong, Li Zhen ^a   Tambyah, Paul A ^a,b   Lum, Lionel H ^a,b   Low, Zhen Jie ^c   Cheng, Ivy ^c   Murali, Tanusya M ^a,b   Wan, Mei Qi ^a   Chua, Horng Ruey ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CONTRAST MEDIUM; FUROSEMIDE; GENTAMICIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; AGED; AGING; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL OUTCOME; CRITICAL ILLNESS; DIALYSIS; DISEASE SEVERITY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SHOCK; CHEMICALLY INDUCED; MORTALITY; RISK FACTOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84994515726     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw296     Document Type: Article

References (36)

1. Hidron AI, Edwards JR, Patel J et al. NHSN annual update: antimicrobialresistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29: 996-1011.
2. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005; 41: 848-54.
3. Principal Causes of Death in Singapore from 2012-2014. https://www. moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html.
4. Avci M, Ozgenc O, Coskuner SA et al. Hospital acquired infections (HAI) in the elderly: comparison with the younger patients. Arch Gerontol Geriatr 2012; 54: 247-50.
5. Zowawi HM, Harris PN, Roberts MJ et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 2015; 12: 570-84.
6. Kumana CR, Yuen KY. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 1994; 47: 902-13.
7. Gilbert DN. Aminoglycosides. In: Mandell GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone, 2005; 328.
8. Galloe AM, Graudal N, Christensen HR et al. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol 1995; 48: 39-43.
9. Smith CR, Lipsky JJ, Laskin OL et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980; 302: 1106-9.
10. Williams PD, Bennett DB, Gleason CR et al. Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob Agents Chemother 1987; 31: 570-4.
11. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1988; 33: 900-11.
12. Moore RD, Smith CR, Lipsky JJ et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984; 100: 352-7.
13. Meyer RD. Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med 1986; 80: 119-25.
14. Baciewicz AM, Sokos DR, Cowan RI. Aminoglycoside-associated nephrotoxicity in the elderly. Ann Pharmacother 2003; 37: 182-6.
15. Koo J, Tight R, Rajkumar V et al. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. Am J Med 1996; 101: 177-83.
16. Chronopoulos A, Cruz DN, Ronco C. Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol 2010; 6: 141-9.
17. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000; 11: 155A.
18. Nicolau DP, Freeman CD, Belliveau PP et al. Experience with a oncedaily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995; 39: 650-5.
19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 1-138.
20. Paquette F, Bernier-Jean A, Brunette V et al. Acute kidney injury and renal recovery with the use of aminoglycosides: a large retrospective study. Nephron 2015; 131: 153-60.
21. Oliveira JF, Silva CA, Barbieri CD et al. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother 2009; 53: 2887-91.
22. Rocco M, Montini L, Alessandri E et al. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study. Crit Care 2013; 17: R174.
23. Picard W, Bazin F, Clouzeau B et al. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Antimicrob Agents Chemother 2014; 58: 7468-74.
24. Chua HR, Horrigan M, McIntosh E et al. Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography. Biomed Res Int 2014; 2014: 506479.
25. Kane-Gill SL, Sileanu FE, Murugan R et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis 2015; 65: 860-9.
26. Selby NM, Shaw S, Woodier N et al. Gentamicin-associated acute kidney injury. QJM 2009; 102: 873-80.
27. van den Akker JP, Egal M, Groeneveld AB. Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care 2013; 17: R98.
28. Chen YC, Jenq CC, Tian YC et al. Rifle classification for predicting in-hospitalmortality in critically ill sepsis patients. Shock 2009; 31: 139-45.
29. Du B, An Y, Kang Y et al. Characteristics of critically ill patients in ICUs in mainland China. Crit Care Med 2013; 41: 84-92.
30. Koulouridis I, Price LL, Madias NE et al. Hospital-acquired acute kidney injury and hospital readmission: a cohort study. Am J Kidney Dis 2015; 65: 275-82.
31. Giuliano RA, Verpooten GA, De Broe ME. The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats. Am J Kidney Dis 1986; 8: 297-303.
32. Fujii T, Uchino S, Takinami M et al. Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol 2014; 9: 848-54.
33. Schmitt R, Coca S, Kanbay M et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008; 52: 262-71.
34. Valette X, Parienti JJ, Plaud B et al. Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: a prospective cohort study. J Crit Care 2012; 27: 322 e1-5.
35. James MT, Samuel SM, Manning MA et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv 2013; 6: 37-42.
36. McCullough PA, Shaw AD, Haase M et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013; 182: 13-29.